[go: up one dir, main page]

BG103574A - Производни на аминофосфоновата киселина с фармацевтична активност - Google Patents

Производни на аминофосфоновата киселина с фармацевтична активност Download PDF

Info

Publication number
BG103574A
BG103574A BG103574A BG10357499A BG103574A BG 103574 A BG103574 A BG 103574A BG 103574 A BG103574 A BG 103574A BG 10357499 A BG10357499 A BG 10357499A BG 103574 A BG103574 A BG 103574A
Authority
BG
Bulgaria
Prior art keywords
hydroxy
formula
aminomethylphosphonate
compound
dimethylpyridyl
Prior art date
Application number
BG103574A
Other languages
Bulgarian (bg)
English (en)
Inventor
Raymond Azoulay
Craig Bentzen
Simon Floret
Robert IFE
Lan Nguyen
Eric Niesor
Hieu Phan
Diep Vinh Van
Original Assignee
Symphar S.A.
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphar S.A., Smithkline Beecham P.L.C. filed Critical Symphar S.A.
Publication of BG103574A publication Critical patent/BG103574A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG103574A 1996-12-20 1999-07-13 Производни на аминофосфоновата киселина с фармацевтична активност BG103574A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9626615.0A GB9626615D0 (en) 1996-12-20 1996-12-20 Novel compounds
PCT/EP1997/007161 WO1998028310A1 (en) 1996-12-20 1997-12-17 Pharmaceutical aminophosphonic acid derivatives

Publications (1)

Publication Number Publication Date
BG103574A true BG103574A (bg) 2000-11-30

Family

ID=10804837

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103574A BG103574A (bg) 1996-12-20 1999-07-13 Производни на аминофосфоновата киселина с фармацевтична активност

Country Status (31)

Country Link
US (2) US6303784B1 (xx)
EP (1) EP0946572B1 (xx)
JP (1) JP2001506667A (xx)
KR (1) KR20000069609A (xx)
CN (1) CN1105117C (xx)
AP (1) AP9901546A0 (xx)
AR (1) AR008541A1 (xx)
AT (1) ATE255117T1 (xx)
AU (1) AU5858898A (xx)
BG (1) BG103574A (xx)
BR (1) BR9714650A (xx)
CA (1) CA2275696A1 (xx)
CO (1) CO4930276A1 (xx)
DE (1) DE69726449T2 (xx)
DZ (1) DZ2377A1 (xx)
EA (1) EA199900580A1 (xx)
GB (1) GB9626615D0 (xx)
HU (1) HUP0002171A3 (xx)
ID (1) ID22053A (xx)
IL (1) IL130334A0 (xx)
MA (1) MA24427A1 (xx)
NO (1) NO993001L (xx)
NZ (1) NZ335884A (xx)
OA (1) OA11068A (xx)
PE (1) PE46799A1 (xx)
PL (1) PL334189A1 (xx)
SK (1) SK81099A3 (xx)
TR (1) TR199901423T2 (xx)
TW (1) TW434221B (xx)
WO (1) WO1998028310A1 (xx)
ZA (1) ZA9711431B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060805A1 (en) 2000-02-16 2001-08-23 Smithkline Beecham P.L.C. Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
US7442689B2 (en) 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
EP1531157B1 (en) * 2000-02-29 2008-03-19 Medicure International Inc. Cardioprotective phosphonates
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
JP2004513891A (ja) * 2000-09-27 2004-05-13 アイレックス オンコロジー リサーチ エス.エイ. α−置換β−アミノエチルホスホネート
US20030114421A1 (en) * 2000-09-27 2003-06-19 Phan Hieu Trung Alpha-substituted beta-aminoethyl phosphonate derivatives
GB0024808D0 (en) 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
GB0025849D0 (en) * 2000-10-23 2000-12-06 Smithkline Beecham Plc Novel compounds
WO2003068240A1 (en) * 2002-02-11 2003-08-21 Ilex Products, Inc. Alpha-substituted heteroarylalkyl phosphonate derivattives
US7208481B2 (en) * 2002-02-19 2007-04-24 Ilex Products, Inc. Aminodiphosphonate apolipoprotein E modulators
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP4824968B2 (ja) * 2005-08-18 2011-11-30 株式会社クレハ ホスホン酸誘導体及びその酸付加塩、並びにそれを用いた農園芸用病害防除剤
MX2013006342A (es) 2010-12-06 2013-08-26 Glaxo Group Ltd Compuestos de pirimidinona para usarse en el tratamiento de enfermedades o afecciones mediadas por fosfolipasa asociada con lipoproteinas a2 (lp-pla2).
KR20140059203A (ko) 2011-07-27 2014-05-15 글락소 그룹 리미티드 2,3-디히드로이미다조[1,2-c]피리미딘-5(1h)-온 화합물의 lp-pla2 억제제로서의 용도
AU2012288865B2 (en) 2011-07-27 2015-10-01 Glaxo Group Limited Bicyclic pyrimidone compounds
JP6199291B2 (ja) 2011-09-01 2017-09-20 グラクソ グループ リミテッドGlaxo Group Limited 新規な結晶形態
AU2014209949B2 (en) 2013-01-25 2016-09-08 Glaxosmithkline Intellectual Property Development Limited 2,3-dihydroimidazol(1,2-c)pyrimidin-5(1h)-one based lipoprotein-associated phospholipase a2 (Lp-PLA2) inhibitors
JP2016505053A (ja) 2013-01-25 2016-02-18 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited Lp‐PLA2の阻害剤としての二環式ピリミドン化合物
CA2899124A1 (en) 2013-01-25 2014-07-31 Glaxosmithkline Intellectual Property Development Limited Compounds
WO2016012916A1 (en) 2014-07-22 2016-01-28 Glaxosmithkline Intellectual Property Development Limited 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2
WO2016012917A1 (en) 2014-07-22 2016-01-28 Glaxosmithkline Intellectual Property Development Limited 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2
BR112022008786A2 (pt) 2019-11-09 2022-07-26 Shanghai Simr Biotechnology Co Ltd Composto, composição, uso do composto ou da composição, e, método para tratar ou prevenir uma complicação diabética, doença relacionada à neuroinflamação ou aterosclerose
CN115304620A (zh) 2021-05-07 2022-11-08 上海赛默罗生物科技有限公司 嘧啶酮衍生物、其制备方法、药物组合物和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683996A5 (fr) 1992-03-05 1994-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
DE4433244A1 (de) 1994-09-19 1996-03-28 Hoechst Ag Aminomethylphosphon- und Aminomethylphosphinsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen
CH690264A5 (fr) 1995-06-30 2000-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques.
GB9626536D0 (en) 1996-12-20 1997-02-05 Symphar Sa Novel compounds

Also Published As

Publication number Publication date
PL334189A1 (en) 2000-02-14
PE46799A1 (es) 1999-06-24
AU5858898A (en) 1998-07-17
CN1240451A (zh) 2000-01-05
DE69726449D1 (en) 2004-01-08
US6303784B1 (en) 2001-10-16
EA199900580A1 (ru) 1999-12-29
ATE255117T1 (de) 2003-12-15
NO993001D0 (no) 1999-06-18
WO1998028310A1 (en) 1998-07-02
IL130334A0 (en) 2000-06-01
CN1105117C (zh) 2003-04-09
KR20000069609A (ko) 2000-11-25
TW434221B (en) 2001-05-16
ZA9711431B (en) 1999-06-21
EP0946572B1 (en) 2003-11-26
EP0946572A1 (en) 1999-10-06
AR008541A1 (es) 2000-01-19
DE69726449T2 (de) 2004-08-26
NO993001L (no) 1999-06-18
US20020082423A1 (en) 2002-06-27
OA11068A (en) 2003-03-10
NZ335884A (en) 2000-11-24
HUP0002171A3 (en) 2002-12-28
HUP0002171A2 (hu) 2001-05-28
MA24427A1 (fr) 1998-07-01
BR9714650A (pt) 2000-10-03
AP9901546A0 (en) 1999-06-30
DZ2377A1 (fr) 2002-12-28
CO4930276A1 (es) 2000-06-27
JP2001506667A (ja) 2001-05-22
CA2275696A1 (en) 1998-07-02
ID22053A (id) 1999-08-26
TR199901423T2 (xx) 1999-10-21
GB9626615D0 (en) 1997-02-05
SK81099A3 (en) 1999-11-08

Similar Documents

Publication Publication Date Title
BG103574A (bg) Производни на аминофосфоновата киселина с фармацевтична активност
AU705206B2 (en) Compounds and pharmaceutical compositions containing them
MXPA98000189A (en) Compounds and pharmaceutical compositions that contains them
WO1998028311A1 (en) Pharmaceutical aminophosphonic acid derivatives
WO1998028312A1 (en) Pharmaceutical aminophosphonic acid derivatives
AU2001294792B2 (en) Alpha-substituted beta-aminoethyl phosphonates
CZ219699A3 (cs) Farmaceutické deriváty kyseliny aminofosfonové
US20030114421A1 (en) Alpha-substituted beta-aminoethyl phosphonate derivatives
US20020111488A1 (en) Beta-substitued beta-aminoethyl phosphonate derivatives
US20050124586A1 (en) Alpha-substituted arylalkyl phosphonate derivatives
JP2005529071A (ja) α−置換ヘテロアリールアルキルホスホン酸エステル誘導体